Brain-Derived Neurotrophic Factor rs6265 polymorphism is associated with severe cancer-related fatigue and neuropathic pain in female cancer survivors

• Published in: Journal of cancer survivorship 2024-12, Vol.18 (6), p.1851-1860
• Main Authors: Goto, Taichi, Von Ah, Diane, Li, Xiaobai, Xiang, Lichen, Kwiat, Catherine, Nguyen, Christopher, Hsiao, Chao-Pin, Saligan, Leorey N.
• Format: Article
• Language: English
• Subjects: Adult; Aged; Brain-derived neurotrophic factor; Brain-Derived Neurotrophic Factor - genetics; Cancer; Cancer Survivors - psychology; Fatigue; Fatigue - etiology; Fatigue - genetics; Female; Females; Gene polymorphism; Genotype; Genotype & phenotype; Health Informatics; Health Promotion and Disease Prevention; Humans; Medicine; Medicine & Public Health; Mental depression; Middle Aged; Neoplasms - complications; Neoplasms - genetics; Neuralgia; Neuralgia - etiology; Neuralgia - genetics; Oncology; Original Paper; Pain; Polymorphism; Polymorphism, Single Nucleotide; Primary Care Medicine; Public Health; Quality of Life Research; Single-nucleotide polymorphism
• ISSN: 1932-2259; 1932-2267; 1932-2267
• DOI: 10.1007/s11764-023-01426-w

Purpose This study examined the relationships between a single-nucleotide polymorphism (SNP) of brain-derived neurotrophic factor ( BDNF ) rs6265 and psychoneurological (PN) symptoms in female cancer survivors. Methods This secondary analysis examined 393 study participants. In addition to demographic variables, self-reported PN symptom scores (anxiety, bodily pain, depression, fatigue, neuropathic pain, and sleep disturbance) were collected using the Patient-Reported Outcomes Measurement Information System and 36-Item Short-Form Health Survey. Buccal swab samples were collected to obtain genotypes for BDNF rs6265 (Val/Val, Val/Met, or Met/Met). The PN symptom scores were compared across genotypes, and the relationships were examined using a regression model. We also explored correlations between different symptoms within each genotype. Results Participants with the Met/Met genotype reported significantly worse cancer-related fatigue and neuropathic pain, which was confirmed by rank-based regression analysis. In addition, cancer-related fatigue was correlated with other PN symptoms, particularly depression. These correlations were stronger in study participants with the Met/Met genotype than those with other genotypes. Conclusion Our study suggests that female cancer survivors with the Met/Met genotype of BDNF rs6265 are likely to experience worse cancer-related fatigue and neuropathic pain and that cancer-related fatigue is a good predictor of co-occurring PN symptoms in this population. Implications for Cancer Survivors Our findings advance the scientific community's understanding of cancer-related PN symptoms experienced by female cancer survivors, especially the unique role of BDNF rs6265 polymorphism in these symptoms. Our findings offer valuable insights for clinical practice that the symptom experience among female cancer survivors may vary based on BDNF genotypes.